Table 4.
Treatment success in both groups
| Efficacy Parameter | VB-001 (N = 78) | ZPTO shampoo (N = 81) | P value |
|---|---|---|---|
| Mean ASFS (normalized) difference (Baseline-Day 14) | 75.6% | 67.9% | 0.0005a |
| Mean pruritus score (normalized) difference (Baseline-Day 9) | 75% | 61% | 0.03a |
| Mean scalp related quality of life index score difference (Baseline-Day 14) | 51.6% | 45.1% | 0.03b |
| Visible hair fall reduction at day 14 (% of subjects) | 41% | 18.5% | <0.05c |
| Softness at day 14 (% of subjects) | 83.3% | 67.9% | <0.05c |
aSignificant by t-test; bSignificant by ANOVA Kruskal Wallis; cSignificant by Chi square test